Board Members

Home › Investors › Board Members

Jeffrey D. Goldberg, Co-Chairman of the Board

President, IncuMed

Mr. Goldberg is the President of IncuMed, the technology incubator for Al Mann's development-level companies. In that capacity he serves as the CEO of RoundTrip Technologies (tagging, tracking, and locating technology), the President of PerQFlo (combined insulin and pump to treat type 2 diabetes), and the CEO of NeuroSystec (combination drug-device to treat tinnitus). Before that, Mr. Goldberg held executive management positions in the health care industry, including Advanced Bionics Corporation, Los Angeles Orthopaedic Hospital (in alliance with UCLA Healthcare), and the Doheny Eye Institute at USC's Keck School of Medicine. He has also worked as an M&A lawyer for Occidental Petroleum Corporation, O'Melveny & Myers, LLP, and McDermott, Will & Emery, LLP.

Kurt M. Cellar, Co-Chairman of the Board

Consultant and Private Investor

Since January 2008, Mr. Cellar has been a consultant and board member to companies in a variety of industries as well as a private investor. From 1999 to 2008 Mr. Cellar worked for the hedge fund Bay Harbour Management, L.C. He was partner and portfolio manager from 2003 until his departure. During his tenure at Bay Harbour, the fund won many investor awards including The Absolute Return "Hedge Fund of the Year" award in 2006. Prior to Bay Harbour, Mr. Cellar was with the private equity firm Remy Investors. Before that, he was a strategy consultant at LEK/Alcar. He is currently a director of Aventine Renewable Energy, Hawaiian Telcom, Six Flags Entertainment (NYSE: Six), US Concrete (NASDAQ: USCR) and Vertis Communications. Mr. Cellar has a Masters in Business Administration from the Wharton School of Business and a BA in Economics/Business from the University of California, Los Angeles. Mr. Cellar is a Chartered Financial Analyst.

Bradley S. Karro, Member of the Board

Principal, Crawford-Ross

Currently a principal at Crawford-Ross, a private equity firm focused on investing in and restructuring healthcare service companies, Mr. Karro has over twenty-five years of healthcare industry experience. Prior to joining Crawford-Ross, Mr. Karro held a number of senior executive positions in the industry, most recently, serving as Executive Vice President of Caremark Rx, a prescription benefit management company. During his time at Caremark RX, he was responsible for mergers and acquisitions, integration planning, information technology, and Medicare product development. Over the course of his career, Mr. Karro has also led one of the nation's largest physician practice management organizations and as well as a managed care company. A native of Toronto, Canada, Mr. Karro received his BA in Honors Business Administration from the University of Western Ontario and started his career with Arthur Andersen & Co.

Donald M. Casey Jr, Member of the Board

Chief Executive Officer, West Wireless Health Institute

Mr. Casey has over 25 years of global healthcare experience and an outstanding track record in identifying and commercializing medical innovations. Mr. Casey is currently the CEO and a member of the Board at the West Wireless Health Institute where he is driving the development of a world-class research organization focused on accelerating wireless health innovations to lower health care costs.

Previously, Mr. Casey served as Worldwide Chairman for Johnson & Johnson's comprehensive care group and member of the Company's Executive committee, where he oversaw its cardiovascular, diagnostic, diabetes and vision care franchises around the world. He was responsible for defining a corporate-wide comprehensive approach to chronic disease management, including leading the development of patient-centric solutions and innovations within the medical device segment for some of the world's most pervasive conditions, including diabetes and cardiovascular disorders. Mr. Casey began his career with Johnson & Johnson in 1985, advancing into executive positions throughout the company's consumer, pharmaceutical and medical device franchises.

Mr. Casey holds an MBA from the University of Notre Dame.

Omar Vaishnavi, Member of the Board

Senior Investment Analyst, BlueMountain Capital

Mr. Vaishnavi is currently a Senior Investment Analyst with BlueMountain Capital Management in New York, where he principally focuses on investing in credit and equities in a variety of industries. Prior to joining BlueMountain, Mr. Vaishnavi spent several years at Silver Point Capital as an investment professional with a primary focus on healthcare and distressed investing. Before that he was an investment banking analyst with UBS. Mr. Vaishnavi graduated Magna Cum Laude with a Bachelor of Science in Economics from The Wharton School at the University of Pennsylvania.